Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

42

Revenue 2017

Cialis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Cialis was produced by Lilly.

A True work of art

Cialis - for erectile dysfunction. There's been a real shift here creatively and for the better.

Pulling the plug

Even DTC spending for erectile dysfunction (ED) drugs, Cialis and Levitra, was cut in the first five months of 2005, after big-buck campaigns last year failed to provide the expected

Pfizer eases back into Viagra promotion

Newcomers such as Cialis (Lilly) and Levitra (GlaxoSmithKline/Schering-Plough) have only marginally expanded the market since their inception in 2003.

Lilly posts rise in sales

Our newer products, including Cymbalta, Cialis and Alimta, continued to perform exceptionally well, while our diabetes care franchise has made good progress.". ... Cialis experienced a 24 per cent increase in sales with a reported total sales of $362.2m

Lilly projects 2008 profits up 14 per cent on 2007

The company expects strong FY08 sales growth for Cymbalta, Cialis (tadalafil) for erectile dysfunction, the cancer drug Alimta (pemtrexed) and the diabetes drugs Byetta (exenatide) and Humalog (insulin lispro).

[ Previous 5 results ] 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics